The 2024 Gold Rush: Unleashing Market Potential

Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.

Get your free information kit NOW, before it's too late.

LUNG Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,636,984.34

Pulmonx Insider Trading History Chart

Pulmonx Share Price & Price History

^$8.81

▼ -0.72 (-7.56%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Urgent Nvidia Warning

From Altimetry | Ad

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…

Pulmonx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$7.49	$8,868.16	306,684
3/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$9.36	$11,082.24	307,868
3/1/2024	David Aaron Lehman	General Counsel	Sell	4,351	$9.06	$39,420.06	145,488
3/1/2024	Geoffrey Beran Rose	Insider	Sell	3,097	$9.06	$28,058.82	239,952
3/1/2024	Glendon E. French, III	CEO	Sell	6,954	$9.06	$63,003.24	1,116,758
3/1/2024	John Mckune	CFO	Sell	1,078	$9.06	$9,766.68	47,410
2/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$14.20	$16,812.80	243,049
2/15/2024	Glendon E. French, III	CEO	Sell	20,000	$14.60	$292,000.00	1,121,344
1/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$13.13	$15,545.92	244,233
1/18/2024	Glendon E. French, III	CEO	Sell	10,000	$12.77	$127,700.00	1,141,344
12/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$12.75	$15,096.00	245,417
12/21/2023	Glendon E. French, III	CEO	Sell	10,000	$12.42	$124,200.00	1,151,344
12/1/2023	David Aaron Lehman	General Counsel	Sell	3,809	$10.34	$39,385.06	149,839
12/1/2023	Geoffrey Beran Rose	Insider	Sell	2,868	$10.34	$29,655.12	246,601
12/1/2023	Glendon E. French, III	CEO	Sell	6,676	$10.34	$69,029.84	1,161,344
12/1/2023	John Mckune	CFO	Sell	942	$10.34	$9,740.28	40,414
11/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.60	$12,550.40	249,469
10/23/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$8.35	$9,886.40	250,653
9/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.51	$12,443.84	251,837
9/1/2023	David Aaron Lehman	General Counsel	Sell	3,772	$10.01	$37,757.72	153,648
9/1/2023	Derrick Sung	CFO	Sell	4,219	$10.00	$42,190.00	391,041
9/1/2023	Geoffrey Beran Rose	Insider	Sell	2,843	$10.01	$28,458.43	253,021
9/1/2023	Glendon E. French, III	CEO	Sell	6,527	$10.01	$65,335.27	1,168,020
8/23/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.54	$12,479.36	255,864
7/20/2023	Glendon E. French, III	CEO	Sell	15,000	$12.68	$190,200.00	1,174,547
6/15/2023	Glendon E. French, III	CEO	Sell	10,000	$12.68	$126,800.00	1,189,547
6/1/2023	David Aaron Lehman	General Counsel	Sell	3,776	$11.48	$43,348.48	157,420
6/1/2023	Derrick Sung	CFO	Sell	4,222	$11.49	$48,510.78	395,260
6/1/2023	Geoffrey Beran Rose	Insider	Sell	2,845	$11.48	$32,660.60	257,048
6/1/2023	Glendon E. French, III	CEO	Sell	6,533	$11.48	$74,998.84	1,199,547
3/1/2023	Derrick Sung	CFO	Sell	1,264	$11.03	$13,941.92	261,482
3/1/2023	Geoffrey Beran Rose	Insider	Sell	1,206	$11.03	$13,302.18	180,993
3/1/2023	Glendon E. French, III	CEO	Sell	2,895	$11.03	$31,931.85	1,032,580
12/1/2022	David Aaron Lehman	General Counsel	Sell	1,069	$5.93	$6,339.17	44,160
12/1/2022	Geoffrey Beran Rose	Insider	Sell	1,055	$5.93	$6,256.15	181,037
12/1/2022	Glendon E. French, III	CEO	Sell	3,631	$5.93	$21,531.83	1,034,313
11/29/2022	Alissa Hsu Lynch	Director	Buy	1,700	$5.51	$9,367.00	11,910
11/8/2022	Richard Ferrari	Director	Buy	5,438	$5.31	$28,875.78	30,035
9/15/2022	Glendon E. French, III	CEO	Sell	25,000	$20.00	$500,000.00	1,027,944
8/18/2022	Glendon E. French, III	CEO	Sell	50,000	$20.59	$1,029,500.00	1,055,884
6/1/2022	David Aaron Lehman	General Counsel	Sell	1,065	$18.05	$19,223.25	46,311
6/1/2022	Geoffrey Beran Rose	Insider	Sell	1,011	$18.05	$18,248.55	183,118
6/1/2022	Glendon E. French, III	CEO	Sell	2,523	$18.05	$45,540.15	1,104,994
3/1/2022	David Aaron Lehman	General Counsel	Sell	458	$25.91	$11,866.78
3/1/2022	Glendon E. French, III	CEO	Sell	1,132	$25.91	$29,330.12
2/17/2022	Glendon E. French, III	CEO	Sell	12,500	$27.22	$340,250.00
1/20/2022	Glendon E. French, III	CEO	Sell	12,500	$25.98	$324,750.00
12/16/2021	Glendon E. French, III	CEO	Sell	25,000	$31.05	$776,250.00
12/15/2021	Geoffrey Beran Rose	Insider	Sell	22,000	$30.55	$672,100.00
12/14/2021	Derrick Sung	CFO	Sell	3,000	$32.89	$98,670.00
12/1/2021	David Aaron Lehman	General Counsel	Sell	383	$32.73	$12,535.59
12/1/2021	Geoffrey Beran Rose	Insider	Sell	355	$32.73	$11,619.15
12/1/2021	Glendon E. French, III	CEO	Sell	1,421	$32.73	$46,509.33
11/18/2021	Glendon E. French, III	CEO	Sell	25,000	$35.98	$899,500.00
11/15/2021	Geoffrey Beran Rose	Insider	Sell	7,000	$39.94	$279,580.00
10/21/2021	Glendon E. French, III	CEO	Sell	25,000	$39.75	$993,750.00
10/15/2021	Geoffrey Beran Rose	Insider	Sell	7,000	$39.44	$276,080.00
9/20/2021	Derrick Sung	CFO	Sell	3,000	$37.35	$112,050.00
9/20/2021	Glendon E. French, III	CEO	Sell	23,571	$37.36	$880,612.56
9/16/2021	Glendon E. French, III	CEO	Sell	25,000	$38.86	$971,500.00	1,155,370
9/15/2021	Geoffrey Beran Rose	Insider	Sell	7,000	$38.12	$266,840.00	159,814
9/1/2021	Derrick Sung	CFO	Sell	383	$40.09	$15,354.47	17,217
9/1/2021	Geoffrey Beran Rose	Insider	Sell	355	$40.09	$14,231.95
9/1/2021	Glendon E. French, III	CEO	Sell	1,421	$40.09	$56,967.89
8/19/2021	Glendon E. French, III	CEO	Sell	25,000	$36.63	$915,750.00
8/16/2021	Geoffrey Beran Rose	Insider	Sell	7,000	$36.71	$256,970.00
7/15/2021	Geoffrey Beran Rose	Insider	Sell	7,000	$38.73	$271,110.00	180,127
7/15/2021	Glendon E. French, III	CEO	Sell	25,000	$38.73	$968,250.00
7/13/2021	Scientific Corp Boston	Major Shareholder	Sell	2,500,000	$37.45	$93,625,000.00
7/12/2021	Daniel P. Florin	Director	Buy	2,500	$40.00	$100,000.00
6/25/2021	Daniel P. Florin	Director	Buy	2,222	$44.12	$98,034.64	5,032
6/17/2021	Glendon E. French, III	CEO	Sell	25,000	$42.96	$1,074,000.00	1,252,359
5/24/2021	Geoffrey Beran Rose	Insider	Sell	4,797	$40.88	$196,101.36
5/20/2021	Glendon E. French, III	CEO	Sell	25,000	$41.95	$1,048,750.00	1,219,825
5/10/2021	Geoffrey Beran Rose	Insider	Sell	4,797	$40.70	$195,237.90	117,692

Urgent Nvidia Warning

From Altimetry | Ad

Click here to access…

SEC Filings (Institutional Ownership Changes) for Pulmonx (NASDAQ:LUNG)

91.04% of Pulmonx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Pulmonx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	989,423	$9.17M	0.0%	+6.4%	2.567%
5/8/2024	Russell Investments Group Ltd.	34,947	$0.32M	0.0%	-41.1%	0.091%
5/7/2024	Sei Investments Co.	72,626	$0.67M	0.0%	+2.5%	0.188%
4/30/2024	Allspring Global Investments Holdings LLC	8,516	$79K	0.0%	+609.7%	0.022%
4/18/2024	Allspring Global Investments Holdings LLC	8,516	$79K	0.0%	+609.7%	0.022%
2/14/2024	Braidwell LP	787,954	$10.05M	0.4%	-20.3%	2.057%
2/13/2024	Rhenman & Partners Asset Management AB	25,000	$0.32M	0.0%	N/A	0.065%
2/13/2024	Pura Vida Investments LLC	477,398	$6.09M	1.9%	-34.3%	1.246%
2/13/2024	Campbell & CO Investment Adviser LLC	85,672	$1.09M	0.1%	+88.8%	0.224%
2/12/2024	Olympiad Research LP	12,012	$0.15M	0.1%	N/A	0.031%
2/9/2024	Primecap Management Co. CA	5,646,451	$71.99M	0.1%	+2.2%	14.740%
2/9/2024	Franklin Resources Inc.	742,412	$9.47M	0.0%	-0.2%	1.938%
2/9/2024	Quest Partners LLC	7,352	$94K	0.0%	N/A	0.019%
2/9/2024	Trexquant Investment LP	24,936	$0.32M	0.0%	-29.9%	0.065%
2/9/2024	Dynamic Technology Lab Private Ltd	12,258	$0.16M	0.0%	N/A	0.032%
2/6/2024	Swiss National Bank	67,500	$0.86M	0.0%	-13.6%	0.176%
2/6/2024	New York Life Investment Management LLC	31,129	$0.40M	0.0%	-2.3%	0.081%
2/5/2024	Victory Capital Management Inc.	853,846	$10.89M	0.0%	-10.2%	2.229%
2/5/2024	Russell Investments Group Ltd.	59,308	$0.76M	0.0%	-17.4%	0.155%
2/1/2024	New York State Common Retirement Fund	17,495	$0.22M	0.0%	+32.7%	0.046%
1/30/2024	Strs Ohio	5,200	$66K	0.0%	-37.3%	0.014%
1/12/2024	SG Americas Securities LLC	9,184	$0.12M	0.0%	N/A	0.024%
12/18/2023	Vanguard Group Inc.	2,023,836	$20.91M	0.0%	+1.0%	5.283%
11/21/2023	Walleye Capital LLC	372,290	$3.85M	0.0%	N/A	0.972%
11/17/2023	Jacobs Levy Equity Management Inc.	505,379	$5.22M	0.0%	-25.7%	1.319%
11/14/2023	Braidwell LP	988,559	$10.21M	0.3%	-1.1%	2.581%
11/14/2023	Deerfield Management Company L.P. Series C	1,017,958	$10.52M	0.2%	-4.4%	2.657%
11/14/2023	Trexquant Investment LP	35,596	$0.37M	0.0%	N/A	0.093%
11/14/2023	PEAK6 Investments LLC	13,009	$0.13M	0.0%	-24.1%	0.034%
11/14/2023	Primecap Management Co. CA	5,522,401	$57.05M	0.0%	+0.0%	14.415%
11/13/2023	Algert Global LLC	117,327	$1.21M	0.1%	+25.2%	0.306%
11/13/2023	Aigen Investment Management LP	10,700	$0.11M	0.0%	N/A	0.028%
11/13/2023	FMR LLC	2,029,835	$20.97M	0.0%	+24.7%	5.298%
11/9/2023	Deutsche Bank AG	46,868	$0.48M	0.0%	-91.3%	0.122%
11/8/2023	Campbell & CO Investment Adviser LLC	45,380	$0.47M	0.1%	+134.4%	0.118%
11/8/2023	L2 Asset Management LLC	19,747	$0.20M	0.2%	N/A	0.052%
11/8/2023	New York Life Investment Management LLC	31,846	$0.33M	0.0%	-13.6%	0.083%
11/7/2023	Barclays PLC	92,938	$0.96M	0.0%	+132.7%	0.244%
11/6/2023	Versor Investments LP	18,123	$0.19M	0.0%	-20.6%	0.048%
11/6/2023	Victory Capital Management Inc.	950,763	$9.82M	0.0%	-2.7%	2.500%
10/26/2023	Strs Ohio	8,300	$85K	0.0%	N/A	0.022%
10/24/2023	Bank of New York Mellon Corp	159,712	$1.65M	0.0%	+2.5%	0.420%
8/15/2023	Braidwell LP	999,362	$13.10M	0.4%	-14.1%	2.628%
8/14/2023	Pura Vida Investments LLC	636,408	$8.34M	1.1%	-0.2%	1.673%
8/14/2023	Graham Capital Management L.P.	11,485	$0.15M	0.0%	N/A	0.030%
8/11/2023	PEAK6 Investments LLC	17,146	$0.23M	0.0%	-66.4%	0.045%
8/11/2023	Campbell & CO Investment Adviser LLC	19,361	$0.25M	0.0%	N/A	0.051%
8/11/2023	Franklin Resources Inc.	743,587	$9.75M	0.0%	+2.5%	1.955%
8/10/2023	Russell Investments Group Ltd.	109,105	$1.43M	0.0%	+20.9%	0.287%
8/7/2023	Principal Financial Group Inc.	11,249	$0.15M	0.0%	N/A	0.030%
8/7/2023	Acadian Asset Management LLC	26,293	$0.34M	0.0%	N/A	0.070%
8/7/2023	Versor Investments LP	22,823	$0.30M	0.1%	+117.4%	0.060%
8/7/2023	New York Life Investment Management LLC	36,864	$0.48M	0.0%	-14.7%	0.098%
8/4/2023	American International Group Inc.	17,655	$0.23M	0.0%	+7.0%	0.047%
8/3/2023	Bank of New York Mellon Corp	155,812	$2.04M	0.0%	+2.0%	0.413%
8/1/2023	Arizona State Retirement System	10,068	$0.13M	0.0%	N/A	0.027%
7/27/2023	Victory Capital Management Inc.	977,344	$12.81M	0.0%	N/A	2.589%
7/25/2023	Olympiad Research LP	13,210	$0.17M	0.2%	N/A	0.035%
7/24/2023	Allspring Global Investments Holdings LLC	4,251	$56K	0.0%	+257.5%	0.011%
7/18/2023	Allspring Global Investments Holdings LLC	4,251	$56K	0.0%	+257.5%	0.011%
5/9/2023	US Bancorp DE	2,316	$26K	0.0%	+229.9%	0.006%
5/9/2023	Russell Investments Group Ltd.	90,270	$1.01M	0.0%	+41.7%	0.239%
5/8/2023	New York Life Investment Management LLC	43,222	$0.48M	0.0%	N/A	0.115%
5/5/2023	Versor Investments LP	10,500	$0.12M	0.0%	-32.3%	0.028%
4/28/2023	SG Americas Securities LLC	11,063	$0.12M	0.0%	N/A	0.029%
4/20/2023	Banque Cantonale Vaudoise	4,300	$48K	0.0%	N/A	0.011%
2/15/2023	General Electric Co.	11,843	$100K	0.0%	N/A	0.032%
2/15/2023	Braidwell LP	1,621,494	$13.67M	0.5%	N/A	4.334%
2/13/2023	GSA Capital Partners LLP	157,494	$1.33M	0.2%	N/A	0.421%
2/10/2023	Franklin Resources Inc.	724,876	$6.11M	0.0%	-0.4%	1.938%
2/10/2023	HRT Financial LP	64,767	$0.55M	0.0%	N/A	0.173%
2/9/2023	Landscape Capital Management L.L.C.	18,993	$0.16M	0.0%	N/A	0.051%
2/9/2023	Denali Advisors LLC	7,400	$62K	0.0%	N/A	0.020%
2/9/2023	Citigroup Inc.	44,862	$0.38M	0.0%	+3,626.1%	0.120%
2/8/2023	Russell Investments Group Ltd.	63,722	$0.54M	0.0%	-33.8%	0.170%
2/7/2023	Handelsbanken Fonder AB	16,100	$0.14M	0.0%	N/A	0.043%
2/7/2023	KPCB XIII Associates LLC	994,971	$8.39M	4.0%	N/A	2.660%
1/30/2023	Versor Investments LP	15,500	$0.13M	0.0%	N/A	0.041%
1/20/2023	CFM Wealth Partners LLC	264,039	$2.23M	0.4%	N/A	0.706%
1/1/2023	California State Teachers Retirement System	37,454	$0.62M	0.0%	-3.6%	0.100%
11/15/2022	Twinbeech Capital LP	50,174	$0.84M	0.0%	N/A	0.134%
11/15/2022	PFM Health Sciences LP	199,703	$3.33M	0.1%	N/A	0.534%
11/15/2022	Prelude Capital Management LLC	21,704	$0.36M	0.0%	N/A	0.058%
11/15/2022	Primecap Management Co. CA	5,432,751	$90.51M	0.1%	+0.7%	14.523%
11/15/2022	Pura Vida Investments LLC	778,978	$12.98M	0.8%	-41.3%	2.082%
11/15/2022	Lord Abbett & CO. LLC	303,680	$5.06M	0.0%	+69.3%	0.812%
11/14/2022	RTW Investments LP	460,847	$7.68M	0.2%	-33.3%	1.232%
11/14/2022	Point72 Asset Management L.P.	526,797	$8.78M	0.0%	+33.8%	1.408%
11/14/2022	Cubist Systematic Strategies LLC	32,201	$0.54M	0.0%	-74.7%	0.086%
11/14/2022	PDT Partners LLC	61,382	$1.02M	0.2%	-8.9%	0.164%
11/14/2022	Moore Capital Management LP	25,152	$0.42M	0.0%	-52.3%	0.067%
11/14/2022	MetLife Investment Management LLC	20,227	$0.34M	0.0%	+12.0%	0.054%
11/14/2022	CenterBook Partners LP	18,654	$0.31M	0.1%	N/A	0.050%
11/8/2022	New York State Common Retirement Fund	24,981	$0.42M	0.0%	+13.1%	0.067%
11/4/2022	Russell Investments Group Ltd.	96,250	$1.60M	0.0%	N/A	0.258%
11/3/2022	Barclays PLC	1,550	$26K	0.0%	-39.5%	0.004%
10/31/2022	SG Americas Securities LLC	19,733	$0.33M	0.0%	-33.2%	0.053%
10/24/2022	Calamos Advisors LLC	41,111	$0.69M	0.0%	N/A	0.110%
10/14/2022	Diversified Trust Co	16,775	$0.28M	0.0%	+28.3%	0.045%
8/16/2022	Woodline Partners LP	431,632	$6.35M	0.1%	-5.5%	1.158%

Data available starting January 2016

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Today's Range

Now: $8.81

$8.78

$9.46

50 Day Range

MA: $8.55

$7.28

$9.82

52 Week Range

Now: $8.81

$7.11

$14.84

Volume

835,778 shs

Average Volume

521,938 shs

Market Capitalization

$339.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of Pulmonx?: Pulmonx's top insider investors include:
Glendon E French III (CEO)
Derrick Sung (CFO)
Geoffrey Beran Rose (Insider)
David Aaron Lehman (General Counsel)
John Mckune (CFO)
Richard Ferrari (Director)
Alissa Hsu Lynch (Director)
Learn More about top insider investors at Pulmonx.
Who are the major institutional investors of Pulmonx?: Pulmonx's top institutional investors include:
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 2.57%
Sei Investments Co. — 0.19%
Russell Investments Group Ltd. — 0.09%
Allspring Global Investments Holdings LLC — 0.02%
Allspring Global Investments Holdings LLC — 0.02%
Learn More about top institutional investors of Pulmonx stock.
Which major investors are selling Pulmonx stock?: In the last quarter, LUNG stock was sold by these institutional investors:
Russell Investments Group Ltd.
During the last year, company insiders that have sold Pulmonx company stock include:
Glendon E French III (CEO)
Derrick Sung (CFO)
Geoffrey Beran Rose (Insider)
David Aaron Lehman (General Counsel)
John Mckune (CFO)
Learn More investors selling Pulmonx stock.
Which major investors are buying Pulmonx stock?: During the last quarter, LUNG stock was purchased by institutional investors including:
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC
Sei Investments Co.
During the last year, these company insiders have bought Pulmonx stock:
Glendon E French III (CEO)
Derrick Sung (CFO)
Learn More investors buying Pulmonx stock.